Appendix cancer differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Appendix_cancer]] | |||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
Line 13: | Line 13: | ||
:*[[Carcinoid Tumor|Carcinoid tumors]] must be differentiated from other diseases that cause [[carcinoid syndrome]] sign and symptoms such as [[palpitation]], [[Flushing|facial flushing]], and [[diarrhea]]. | :*[[Carcinoid Tumor|Carcinoid tumors]] must be differentiated from other diseases that cause [[carcinoid syndrome]] sign and symptoms such as [[palpitation]], [[Flushing|facial flushing]], and [[diarrhea]]. | ||
:*In contrast, [[adenocarcinoma]]<nowiki/>s and cystadenocarcinomas must be differentiated from other diseases that cause [[Appendicitis|acute appendicitis]] or present with [[pseudomyxoma peritonei]], such as [[Colorectal cancer|colorectal cancers]] and [[Appendix cancer echocardiography and ultrasound|appendix mucoceles]]. | :*In contrast, [[adenocarcinoma]]<nowiki/>s and cystadenocarcinomas must be differentiated from other diseases that cause [[Appendicitis|acute appendicitis]] or present with [[pseudomyxoma peritonei]], such as [[Colorectal cancer|colorectal cancers]] and [[Appendix cancer echocardiography and ultrasound|appendix mucoceles]]. | ||
<small> | |||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
Line 122: | Line 122: | ||
* CK 20 | * CK 20 | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Carcinoid Tumor|Carcinoid]] | ||
tumor<sup>2</sup> | [[Carcinoid Tumor|tumor]]<sup>2</sup> | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 254: | Line 254: | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix Mucocele | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix Mucocele | ||
| style="background: #DCDCDC; padding: 5px;" |Mucosal | | style="background: #DCDCDC; padding: 5px;" |Mucosal | ||
[[hyperplasia]] | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
Line 290: | Line 290: | ||
or | or | ||
retention | [[Mucous retention cyst|retention]] | ||
cyst | [[Mucous retention cyst|cyst]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
Line 303: | Line 303: | ||
| style="background: #F5F5F5; padding: 5px;" |Degenerative<br>epithelial<br>changes<br>because of<br>obstruction | | style="background: #F5F5F5; padding: 5px;" |Degenerative<br>epithelial<br>changes<br>because of<br>obstruction | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" | Mucinous cyst | | style="background: #DCDCDC; padding: 5px;" | Mucinous cyst- | ||
adenomas | adenomas | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
Line 325: | Line 325: | ||
* Similar<br>to<br>colon<br>adenomatous<br>polyps or<br> villous <br>adnomas | * Similar<br>to<br>colon<br>adenomatous<br>polyps or<br> villous <br>adnomas | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" | Mucinous cystadeno- | | style="background: #DCDCDC; padding: 5px;" | Mucinous [[Cystadenocarcinoma staging|cystadeno-]] | ||
carcinomas | [[Cystadenocarcinoma staging|carcinomas]] | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
Line 640: | Line 640: | ||
|} | |} | ||
<small><sup>1</sup></small> | <small><sup>1</sup></small> [[Adenocarcinoma]]<nowiki/>s usually present with appendicitis, barely they might present with [[Pseudomyxoma peritonei]]; meanwhile [[pseudomyxoma peritonei]] is more prevalent in perforated [[mucocele]], goblet cell tumor or high stages of [[Adenocarcinoma|adenocarcinoma.]] | ||
<sup>2</sup> Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to | <sup>2</sup> Generally [[Vermiform appendix|appendix]] [[Carcinoid Tumor|carcinoids]] are [[asymptomatic]], they were only become symptomatic if they [[Liver mass|metastasize to the liver,]] or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendicea[[Adenocarcinoma|l adenocarcinoma]]. Any patient with [[carcinoid syndrome]] should be evaluated for [[Carcinoid|appendix carcinoid]]<nowiki/>s. | ||
<sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer. | <sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer. | ||
<sup>4</sup> '''Imaging''' '''is not a reliable method to''' '''distinguish between neoplastic and''' ''' | <sup>4</sup> '''[[Imaging]]''' '''is not a reliable method to''' '''distinguish between [[Cancer|neoplastic]] and''' '''[[Neoplasm|non-neoplastic]] lesions''', hence every patient should undergo [[surgery]], appendectomy and [[Histopathology|histopathologic]] evaluation of the lesion | ||
<nowiki>*</nowiki>'''Abbreviations:''' RLQ: Right Lower Quadrant, AFP: Alpha | <nowiki>*</nowiki>'''Abbreviations:''' RLQ: Right Lower Quadrant, [[Alpha-fetoprotein|AFP]]: [[Alpha-fetoprotein]], [[Human chorionic gonadotropin|HCG: Human chorionic gonadotropin]], [[Lactate dehydrogenase|LDH: Lactate Dehydrogenase]], [[Carcinoembryonic antigen|CEA: Carcinoembryonic antigen]], [[CA-125|CA-125: Cancer antigen 125]], [[5-Hydroxyindoleacetic acid|5-HIAA: Urinary 5-hydroxyindoleacetic acid]] , [[Chromogranin A|CgA: Serum Chromogranin A]] ,PU: Periumbelical, TR: [[Tricuspid regurgitation]] | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Surgery]] | |||
[[Category:Medicine]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Differential diagnosis]] |
Latest revision as of 13:26, 15 July 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
Differentiating appendix cancer from other Diseases
- Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
- As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype.
- Carcinoid tumors must be differentiated from other diseases that cause carcinoid syndrome sign and symptoms such as palpitation, facial flushing, and diarrhea.
- In contrast, adenocarcinomas and cystadenocarcinomas must be differentiated from other diseases that cause acute appendicitis or present with pseudomyxoma peritonei, such as colorectal cancers and appendix mucoceles.
Diseases | Clinical manifestations | Para-clinical findings | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histo-
pathology | |||||||||||||
Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities | |||
Appendix cancer | Adeno- | +/- | -/+ | <math>\downarrow</math> |
|
- | - | - |
|
|
|
Positron emission tomography (PET) |
Gross pathology:
Microscopic
IHC:
| ||
Carcinoid | +/- | - | <math>\uparrow</math> |
|
- | - | + |
Ki67: |
|
Gross pathology:
Microscopic
IHC:
| |||||
Goblet
cell carcinoid |
+ | +/- | <math>\uparrow</math> |
|
+/- | + |
|
+/- |
|
Unfortunately, compared to the other carcinoid tumors of appendix, GCC is more aggressive and patients with GCC generally present at higher stages. Hence, in addition to the above mentioned general findings for appendix cancers, imaging studies should look for evidences of peritoneal involvement, bone metastasis, lymphadenopathy, and metastatic lesions in ovaries and/or prostate. |
Gross
Microscopic
| ||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology | |
Appendix Mucocele | Mucosal | - | - | - |
|
- | +/- | N/A | - | N/A |
|
Rounded right iliac fossa mass
|
|
N/A | Similar to hyperplastic colon polyp |
Simple
or |
- | - | - | - | +/- | - | - | N/A | Degenerative epithelial changes because of obstruction | ||||||
Mucinous cyst-
adenomas |
+/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+/- | +/- | If develop | - |
| ||||||
Mucinous cystadeno- | +/- | +/- | <math>\uparrow</math><math>\downarrow</math> | +/- | +/- | - | - |
| |||||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra- sounography |
Other diagnostic studies and imaging modalities |
Histo-
pathology | |
Ovarian cancer | +/- | +/- | +/-<math>\downarrow</math> |
|
+ | +/- | - |
|
|
|
N/A | Depends on the tumor type. You may find the details here. | |||
Colorectal cancer | +/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+ | +/- | Colonoscopy
Carcinoids
|
-/+(Carcinoid tumors) |
|
Generally not recommended: may evaluate liver metastasis or presence of fluid in abdominal cavity, but it is neither sensitive nor specific. |
PET scan, Endoscopy, Colonoscopy, |
| |||
Pseudomyxoma | + | + | <math>\uparrow</math><math>\downarrow</math> | Bloating | - | + | Ascites | - |
|
|
Charact- |
|
18F-FDG PET scan |
IHC: | |
Carcinoid syndrome | -/+ | - | <math>\uparrow</math> | - | - | + | Depends on the tumor type:
|
Depends on the primary tumor location and type |
|
IHC:
| |||||
Appendicitis 3 | PU, RLQ |
- | <math>\uparrow</math><math>\downarrow</math> | Nausea & vomiting, decreased |
+/- | + |
|
- |
|
Increased fluid signal on T2 weighted sequence |
Evidences of inflammation
|
Tc-99m labeled anti- CD15 antibodies |
Evidences of inflammation | ||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
frequ- f ency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology |
1 Adenocarcinomas usually present with appendicitis, barely they might present with Pseudomyxoma peritonei; meanwhile pseudomyxoma peritonei is more prevalent in perforated mucocele, goblet cell tumor or high stages of adenocarcinoma.
2 Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendiceal adenocarcinoma. Any patient with carcinoid syndrome should be evaluated for appendix carcinoids.
3 Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer.
4 Imaging is not a reliable method to distinguish between neoplastic and non-neoplastic lesions, hence every patient should undergo surgery, appendectomy and histopathologic evaluation of the lesion
*Abbreviations: RLQ: Right Lower Quadrant, AFP: Alpha-fetoprotein, HCG: Human chorionic gonadotropin, LDH: Lactate Dehydrogenase, CEA: Carcinoembryonic antigen, CA-125: Cancer antigen 125, 5-HIAA: Urinary 5-hydroxyindoleacetic acid , CgA: Serum Chromogranin A ,PU: Periumbelical, TR: Tricuspid regurgitation